4//SEC Filing
Cini John K. 4
Accession 0001641172-25-019778
CIK 0001106838other
Filed
Jul 14, 8:00 PM ET
Accepted
Jul 15, 7:35 PM ET
Size
5.6 KB
Accession
0001641172-25-019778
Insider Transaction Report
Form 4
Cini John K.
Chief Scientific Officer
Transactions
- Award
Common Stock
2025-07-11+12,000→ 14,116 total
Footnotes (3)
- [F1]On July 11, 2025, the Reporting Person was granted 12,000 restricted stock units, which will be settled in shares of common stock, par value $0.0001. The restricted stock units vest as to 100% of the restricted stock units on the earlier of (i) January 8, 2026, or (ii) the date of a "Change in Control" (as defined under the Issuer's 2020 Omnibus Equity Incentive Plan).
- [F2]Includes unvested restricted stock units.
- [F3]All amounts reflect the Issuer's 1:22 reverse stock split effective as of August 31, 2023 and 1:8 reverse stock split effective as of September 30, 2024.
Documents
Issuer
Sonnet BioTherapeutics Holdings, Inc.
CIK 0001106838
Entity typeother
Related Parties
1- filerCIK 0001806526
Filing Metadata
- Form type
- 4
- Filed
- Jul 14, 8:00 PM ET
- Accepted
- Jul 15, 7:35 PM ET
- Size
- 5.6 KB